Nexium Bone Fracture Lawsuit Filed By Ohio Woman
An Ohio woman has filed a lawsuit against AstraZeneca, alleging that she suffered bone deterioration and fractures from Nexium, a popular acid reflux drug.
Tag Archives: Protonix
-
-
Prilosec, Nexium Bone Fracture Risks May Be Dose Specific: FDA
According to an update provide by federal drug regulators this week, the risk of bone fractures from Nexium, Prilosec, Prevacid and other heartburn drugs only applies to prescription strength versions…
-
Prilosec, Nexium, Other PPIs Can Cause Low Magnesium Levels: FDA
Prescription strength Prilosec, Nexium and similar stomach acid reducing drugs, known as proton pump inhibitors (PPIs), will have to carry new label warnings alerting consumers to a risk of low…
-
Nexium, Zantac, Other Heartburn Drugs Increase Risk of Pneumonia: Study
Heartburn drugs like Nexium, Prilosec and Zantac may be linked to an increased risk of pneumonia, according to the findings of a new study conducted by South Korean researchers.
-
Bone Fracture Warning Added to Nexium, Prilosec, Other Hearburn Drugs
The FDA is requiring that additional information be provided by several pharmaceutical companies about the risk of bone fractures from Nexium, Prilosec, Prevacid and other heart burn medications.
-
Prevacid, Nexium Side Effects Linked to Increased Bone Fracture Risk: Study
The findings of a recently released study indicate that women taking Nexium, Prilosec and other popular acid-fighting medications may face an increased risk of bone fractures. At the same time,…
-
Prilosec Side Effects Interfere with Effectiveness of Plavix: FDA Warns
The FDA has issued a public health advisory warning that side effects of Prilosec, a stomach acid reducer, may interfere with the effectiveness of Plavix, an anti-blood clotting medication, increasing…
-
Protonix May Increase Risk of Pneumonia Over Zantac for Critically Ill: Study
New research suggests that side effects of Protonix, a stomach acid reducer, may triple the risk of pneumonia for critically ill patients when compared to the competing medication, Zantac.
